Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000610117 | SCV000713191 | uncertain significance | not specified | 2017-04-14 | criteria provided, single submitter | clinical testing | The *4+8T>C variant in KRAS has not been previously reported in affected individ uals. This variant has been identified in 5/111504 European chromosomes by the G enome Aggregation Database (gnomAD, http://gnomAD.broadinstitute.org; dbSNP rs75 2925099). Please note that for diseases with clinical variability, reduced penet rance, or recessive inheritance, pathogenic variants may be present at a low fre quency in the general population. Conservation analysis suggest that the *4+8T>C variant may not impact the protein, though this information is not predictive e nough to rule out pathogenicity. Please note, this variant occurs near an altern ative transcript. Functional studies provide some evidence that mice lacking thi s alternate transcript are viable, fertile, and show no histopathological abnorm alities (Plowman 2003). In summary, the clinical significance of the *4+8T>C va riant is uncertain. |